Phage display identification of nanomolar ligands for human NEDD4-WW3: Energetic and dynamic implications for the development of broad-spectrum antivirals
Metadata
Show full item recordAuthor
Castillo, Francisco; Corbi Verge, Carles; Murciano Calles, Javier; Candel, Adela M.; Iglesias Bexiga, Manuel; Ruiz Sanz, Javier; Martínez Herrerías, José Cristóbal; Luque Fernández, IreneEditorial
Elsevier
Materia
NEDD4 WW domains NEDD4-WW3 domain Drug discovery Polyproline recognition Broad-spectrum antivirals Phage display Molecular dynamics simulations Calorimetry Nuclear magnetic resonance
Date
2022-03-05Referencia bibliográfica
Francisco Castillo... [et al.]. Phage display identification of nanomolar ligands for human NEDD4-WW3: Energetic and dynamic implications for the development of broad-spectrum antivirals, International Journal of Biological Macromolecules, Volume 207, 2022, Pages 308-323, ISSN 0141-8130, [https://doi.org/10.1016/j.ijbiomac.2022.03.010]
Sponsorship
Spanish Government BIO2016-78746-C2-1-R PID2020-112895RB-100 AEI/FEDER EU funds AI138052 AI138630; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA P10-CVI-5915; German Research Foundation (DFG); University of GranadaAbstract
The recognition of PPxY viral Late domains by the third WW domain of the human HECT-E3 ubiquitin ligase
NEDD4 (NEDD4-WW3) is essential for the budding of many viruses. Blocking these interactions is a promising
strategy to develop broad-spectrum antivirals. As all WW domains, NEDD4-WW3 is a challenging therapeutic
target due to the low binding affinity of its natural interactions, its high conformational plasticity, and its
complex thermodynamic behavior. In this work, we set out to investigate whether high affinity can be achieved
for monovalent ligands binding to the isolated NEDD4-WW3 domain. We show that a competitive phage-display
set-up allows for the identification of high-affinity peptides showing inhibitory activity of viral budding. A
detailed biophysical study combining calorimetry, nuclear magnetic resonance, and molecular dynamic simulations
reveals that the improvement in binding affinity does not arise from the establishment of new interactions
with the domain, but is associated to conformational restrictions imposed by a novel C-terminal -LFP motif in the
ligand, unprecedented in the PPxY interactome. These results, which highlight the complexity of WW domain
interactions, provide valuable insight into the key elements for high binding affinity, of interest to guide virtual
screening campaigns for the identification of novel therapeutics targeting NEDD4-WW3 interactions.